Chemplast Sanmar Ltd

Q3 FY23 Earnings Call Analysis

Chemicals & Petrochemicals

Full Stock Analysis
fundraise: No informationcapex: Yesrevenue: Category 3margin: Category 3orderbook: Yes
💰

fundraise

Any current/future new fundraising through debt or equity?

The transcript does not explicitly mention any current or future fundraising plans through debt or equity. However, it notes the following relevant financial points: - As of September 30, 2023, consolidated net debt stood at Rs. 321 crores, mainly due to project loans drawn during H1 FY '24. - The company has ongoing capital investments, including Rs. 680 crores for the Custom Manufacturing expansion (Phase 2) plus Rs. 85 crores earlier invested. - No specific mention was made of new debt or equity fundraising plans beyond drawing project loans for ongoing expansions. In summary, while the company has project-related borrowing already in place, there is no explicit discussion in this call transcript about raising new funds through debt or equity in the near future.
🏗️

capex

Any current/future capex/capital investment/strategic investment?

- Chemplast Sanmar is commissioning Phase 2 of their multipurpose block by the end of FY '24, expanding Custom Manufacturing capacity to an estimated 4,500 tons. - A Paste PVC capacity expansion by 41,000 tons is expected to be commissioned in Q3 FY '24. - The gross block investment for the Custom Manufacturing business will total approximately Rs. 765 crores (Rs. 680 crores current plus Rs. 85 crores earlier). - The new production block commissioning facilitates growth and onboarding of new customers in Custom Manufacturing. - The company plans additional new production capacity beyond the current 4,500-ton capability to support medium to long-term growth targets, including achieving Rs. 1,000 crores in Custom Manufacturing revenues over 3-4 years. - Projects are progressing on schedule, with confidence in delivering improved future performance.
📊

revenue

Future growth expectations in sales/revenue/volumes?

- Custom Manufacturing business is on track to achieve 20-25% growth this year compared to last year (page 4). - With recent signing of the third LOI with a global agrochemical innovator, there is strong visibility for steady-state capacity utilization of the new production block (page 4). - Target to achieve Rs. 1,000 crores revenue from Custom Manufacturing in the next 3-4 years (page 4). - Deliveries of molecules for which LOIs have been signed will commence from H2 of this year (page 4). - Suspension PVC demand continues to be strong, with production volumes increasing (page 12). - Commissioning of Phase 2 of the multipurpose block by end of FY '24 will allow for further growth (page 4). - Paste PVC capacity expansion of 41,000 tons to be commissioned in Q3 FY '24 (page 4). - Medium to long-term outlook remains healthy despite near-term headwinds (page 4).
📈

margin

Future growth expectations in earnings/operating earnings/profits/EPS?

- Chemplast Sanmar aims for 20-25% growth in the Custom Manufacturing business in the current year compared to last year, targeting Rs. 1,000 crores revenue in 3-4 years. - Phase 2 of the multipurpose block and Paste PVC capacity expansion (41,000 tons) are expected to commission by FY '24 end, increasing production and revenues. - PVC business recovery and margin stabilization are anticipated over the next 2-3 quarters amid gradual demand improvement, despite global weakness and Chinese market slowdown. - EBITDA improved to Rs. 46 crores in Q2 FY '24 from a loss in Q1, with expectations of a healthy performance going forward as volumes and pricing stabilize. - Medium to long-term outlook remains robust due to strong infrastructure and real estate demand, expansion projects, and diversified specialty chemical pipeline growth. - Stable pricing and resolution of import dumping issues could enhance operating leverage and profitability.
📋

orderbook

Current/ Expected Orderbook/ Pending Orders?

- Chemplast Sanmar has announced receiving Letters of Intent (LOIs) for several custom manufacturing molecules. - The LOIs precede formal supply agreements, typically spanning 3 to 5 years with volume commitments and pricing formulas. - The new custom manufacturing orders include 9 existing molecules (mostly intermediates) and at least 3 new LOIs, with the latest including the first active ingredient (AI) from a new customer pipeline. - The AI being developed is a new molecule that the company expects to supply as the first external manufacturer, with a long runway extending beyond 5 years due to patent protection. - The capacity after commissioning of Phase 2 of the multipurpose block is estimated around 4,500 metric tons, expected to be fully utilized with these orders. - The company anticipates steady growth in custom manufacturing driven by these and future molecules but has not disclosed a specific total order book value yet.